^{1.Cooper CJ, El-Shiekh RA, Cohen DJ, et al. Effect of transradial access on quality of life and cost of cardiac catheterization:A randomized comparison. Am Heart J. 1999 Sep;138(3 Pt 1):430-6.}

^{2.Kok MM, Weernink MGM, von Birgelen C, Fens A, van der Heijden LC, van Til JA. Patient Preference for Radial versus Femoral Vascular Access for Elective Coronary Procedures: The PREVAS Study. Catheter. Cardiovasc. Interv. 2018;91(1):17‒24.}

^{3.Basu D, Singh PM, Tiwari A, Goudra B. Meta-analysis comparing radial versus femoral approach in patients 75years and older undergoing percutaneous coronary procedures. Indian Heart Journal. 2017;69(5):580-588.}

^{4.Jolly SS, Amlani S, Hamon M, Yusuf S, Mehta SR. Radial versus femoral access for coronary angiography or intervention and the impact on major bleeding and ischemic events: a systematic review and meta-analysis of randomized trials. Am Heart J. 2009;157(1):132-40.}

^{5.Kern MJ. Radial Access in Practice. Tips for starting a successful program. Cardiac Interventions Today. September/October 2015.}

^{6.Bunte MC, Cohen DJ, Jaff MR, et al. Long term clinical and quality of life outcomes after stenting of femoropopliteal artery stenosis:3year results from the ST ROLL study. Catheter Cardiovasc Interv. 2018;92:106 114.}

^{7.Matsumi J, Tobita K, Shishido K, et al. Long term outcomes of SMART stent implantation in patients with femoro popliteal disease. Catheter Cardiovasc Interv. 2016;88(5):832-841.}

^{8.Iida O, et al. Efficacy of the S.M.A.R.T. Control vs. Other Stents for Aortoiliac Occlusive Disease in Contemporary Clinical Practice. Journal of Endovascular Therapy 2013 Jun; 20(3): 431-439.}

^{9.Osamu Iida et al., Self-Expanding Nitinol Stent vs Percutaneous Transluminal Angioplasty in the Treatment of Femoropopliteal Lesions: 3-Year Data From the SM-01 Trial. J Endovasc Ther . 2019 Apr;26(2):158-167}

^{10. Cordis 2021 Data on File}